Jenburkt Pharmaceuticals Limited JENBURPH

Latest filings

• General25 22 Sept, 13:20 · BSE
  Intimation regarding admission of Equity shares of the Company under " Permitted to trade" category on National Stock Exchange of India Limited.
• Routine15 22 Sept, 13:04 · BSE
  Intimation of closure of trading window of the Jenburkt Pharmaceuticals Limited as per the SEBI(Prohibition of Insider Trading) Regulations, 2015.
• Management change38 18 Sept, 16:23 · BSE
  Intimation about Resignation of a Senior Management Personnel of the Company.
• Management change73 4 Sept, 21:34 · BSE
  Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April, 2027 to 31st March, 2032, Approved with requisite ....
• Routine15 4 Sept, 21:23 · BSE
  Submission of consolidated Voting Results and Scrutinizer's Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September, 2026.
• Routine15 4 Sept, 20:40 · BSE
  Proceedings of the 41st Annual General Meeting of the Company held on Friday, 04th September, 2026.
• Routine15 4 Sept, 20:35 · BSE
  Summary of the proceedings of the 41st Annual General Meeting of the Company held on Friday, 04th September, 2026.
• Management change70 4 Sept, 12:40 · BSE
  Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management
• Routine15 7 Aug, 11:41 · BSE
  Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication
• Board meeting48 6 Aug, 19:59 · BSE
  Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 06Th August, 2026.

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.